Biodegradable scaffolds - Delivery systems for cell therapies

Expert Opinion on Biological Therapy

Volumn 6, Issue 5, 2006, Pages 485-498

  Yang, Ying ^b   El Haj, Alicia J ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b NONE

Author keywords

Biomimetic; Capsules; Cell encapsulation; Cell therapies; Scaffolds; Tissue engineering

Indexed keywords

POLYMER;

ADOPTIVE IMMUNOTHERAPY; BIOCOMPATIBILITY; BIODEGRADABILITY; IMPLANTATION; IN VITRO STUDY; REVIEW; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMIMETIC MATERIALS; BIOPOLYMERS; CELLS, CULTURED; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PHARMACEUTICAL PREPARATIONS; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 33646562882     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.6.5.485     Document Type: Review

References (119)

1. SHIEH SJ, VACANTI JP: State-of-the-art tissue engineering: from tissue engineering to organ building. Surgery (2005) 137(1):1-7.
2. DUNNETT SB, BJORKLUND A: Prospects for new restorative and neuroprotective treatments in Parkinsons disease. Nature (1999) 399(6738 Suppl.):A32-A39.
3. OLIVEIRA AA JR, HODGES HM: Alzheimer's disease and neural transplantation as prospective cell therapy. Curr. Alzheimer Res. (2005) 2(1):79-95.
4. TUAN RS, BOLAND G, TULI R: Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther. (2003) 5(1):32-45.
5. ZUK PA, ZHU M, MIZUNO H et al.: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. (2001) 7(2):211-228.
6. BRITTBERG M: Autologous chondrocyte transplantation. Clin. Orthop. Relat. Res. (1999) 367(Suppl.):S147-S155.
7. EHRLICH HP: Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds. Am. J. Surg. (2004) 187(5A):29S-33S.
8. BRITTBERG M, LINDAHL A, NILSSON A et al.: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. (1994) 331(14):889-895.
9. ROBERTS S, MCCALL IW, DARBY AJ et al.: Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology. Arthritis Res. Ther. (2003) 5(1):R60-R73.
10. RUANO-RAVINA A, JATO DIAZ M: Autologous chondrocyte implantation: a systematic review. Osteoarthritis Cartilage (2006) 14(1):47-51.
11. BRITTBERG M, TALLHEDEN T, SJOGREN-JANSSON B et al.: Autologous chondrocytes used for articular cartilage repair: an update. Clin. Orthop. Relat. Res. (2001) 391(Suppl.):S337-348.
12. WHITTAKER JP, SMITH G, MAKWANA N et al.: Early results of autologous chondrocyte implantation in the talus. J. Bone Joint Surg. Br. (2005) 87(2):179-183.
13. PETERSON L, MINAS T, BRITTBERG M, LINDAHL A: Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years. J. Bone Joint Surg. Am. (2003) 85-A(Suppl. 2):17-24.
14. YANNAS IV, BURKE JF: Design of an artificial skin. I. Basic design principles. J. Biomed. Mater. Res. (1980) 14(1):65-81.
15. KEARNEY JN: Clinical evaluation of skin substitutes. Burns (2001) 27(5):545-551.
16. BANNASCH H, FOHN M, UNTERBERG T, BACH AD, WEYAND B, STARK GB: Skin tissue engineering. Clin. Plast. Surg. (2003) 30(4):573-579.
17. LAZAROW A, WELLS LJ, CARPENTER AM et al.: The Banting Memorial Lecture 1973: Islet differentiation, organ culture, and transplantation. Diabetes (1973) 22(12):877-912.
18. ORIVE G, HERNANDEZ RM, GASCON AR, IGARTUA M, PEDRAZ JL: Encapsulated cell technology: from research to market. Trends Biotechnol. (2002) 20(9):382-387.
19. ORIVE G, HERNANDEZ RM, GASCON AR et al.: Cell encapsulation: promise and progress. Nat. Med. (2003) 9(1):104-107. •• This article highlights the progress and hurdles in cell encapsulation research.
20. DUNNETT SB, ROSSER AE: Cell therapy in Huntington's disease. NeuroRx. (2004) 1(4):394-405.
21. BLOCH J, BACHOUD-LEVI AC, DEGLON N et al.: Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a Phase I study. Hum. Gene Ther. (2004) 15(10):968-975.
22. ROSSER AE, BARKER RA, HARROWER T et al.: Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J. Neurol. Neurosurg. Psychiatry (2002) 73(6):678-685.
23. GRIFFITH LG, NAUGHTON G. Tissue engineering-current challenges and expanding opportunities. Science (2002) 295(5557):1009-1014.
24. SITTINGER M, HUTMACHER DW, RISBUD MV: Current strategies for cell delivery in cartilage and bone regeneration. Curr. Opin. Biotechnol. (2004) 15(5):411-418. •• This article address the key issues and strategies for skeletal tissue engineering.
25. RISBUD M: Tissue engineering: implications in the treatment of organ and tissue defects. Biogerontology (2001) 2(2):117-125.
26. AHSAN T, NEREM RM: Bioengineered tissues: the science, the technology, and the industry. Orthod. Craniofac. Res. (2005) 8(3):134-140.
27. HUBBELL JA: Biomaterials in tissue engineering. Biotechnology (NY) (1995) 13(6):565-576.
28. LANGER R, VACANTI JP: Tissue engineering. Science (1993) 260(5110):920-926.
29. YANG Y, EL HAJ AJ: Bone tissue engineering. Scope (2004) 13(3):33-35.
30. MALDA J, WOODFIELD TB, VAN DER VLOODT F et al.: The effect of PEGT/PBT scaffold architecture on the composition of tissue engineered cartilage. Biomaterials (2005) 26(1):63-72.
31. FREED LE, VUNJAK-NOVAKOVIC G, BIRON RJ et al.: Biodegradable polymer scaffolds for tissue engineering. Biotechnology (NY) (1994) 12(7):689-693.
32. CHEN G, USHIDA T, TATEISHI T: Development of biodegradable porous scaffolds for bone tissue engineering. Mater. Sci. Eng. (2001) 17:63-69.
33. HUTMACHER DW, SCHANTZ T, ZEIN I et al.: Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J. Biomed. Mater. Res. (2001) 55:203-216.
34. YANG Y, YIU HH, EL HAJ AJ: On-line fluorescent monitoring the degradation of polymeric scaffolds for tissue engineering. Analyst (2005) 130:1502-1506.
35. HUTMACHER DW: Scaffolds in tissue engineering bone and cartilage. Biomaterials (2000) 21:2529-2543.
36. EL-GHALBZOURI A, LAMME EN, VAN BLITTERSWIJK C et al.: The use of PEGT/PBT as a dermal scaffold for skin tissue engineering. Biomaterials (2004) 25(15):2987-2996.
37. CHEN GQ, WU Q: The application of polyhydroxyalkanoates as, tissue engineering materials. Biomaterials (2005) 26(33):6565-6578.
38. COOPER JA, LU HH, KO FK et al.: Fiber-based tissue-engineered scaffold for ligament replacement: design considerations and in vitro evaluation. Biomaterials (2005) 26(13):1523-1532.
39. SHERWOOD JK, RILEY SL, PALAZZOLO R et al.: A three-dimensional osteochondral composite scaffold for articular cartilage repair. Biomaterials (2002) 23(24):4739-4751.
40. JEONG SI, KIM SH, KIM YH et al.: Manufacture of elastic biodegradable PLCL scaffolds for mechano-active vascular tissue engineering. J. Biomater. Sci. Polym. Ed. (2004) 15(5):645-660.
41. GUAN J, FUJIMOTO KL, SACKS MS et al.: Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications. Biomaterials (2005) 26(18):3961-3971.
42. HEIJKANTS RG, VAN CALCK RV, VAN TIENEN TG et al.: Uncatalyzed synthesis, thermal and mechanical properties of polyurethanes based on poly(ε- caprolactone) and 1,4-butane diisocyanate with uniform hard segment. Biomaterials (2005) 26:4219-4228.
43. D'EREDITA R, MARSH RR, LORA S et al.: A new absorbable pressure-equalizing tube. Otolaryngol. Head Neck Surg. (2002) 127(1):67-72.
44. NOVIKOV LN, NOVIKOVA LN, MOSAHEBI A et al.: A novel biodegradable implant for neuronal rescue and regeneration after spinal cord injury. Biomaterials (2002) 23(16):3369-3376.
45. DOMB AJ, MANOR N, ELMALAK O: Biodegradable bone cement compositions based on acrylate and epoxide terminated poly(propylene fumarate) oligomers and calcium salt compositions. Biomaterials (1996) 17(4):411-417.
46. PANOYAN A, QUESNEL R, HILDGEN P: Injectable nanospheres from a novel multiblock copolymer: cytocompatibility, degradation and in vitro release studies. J. Microencapsul. (2003) 20(6):745-758.
47. FUJIMOTO M, ISOBE M, YAMAGUCHI S et al.: Poly(ethylene glycol) hydrogels cross-linked by hydrolyzable polyrotaxane containing hydroxyapatite particles as scaffolds for bone regeneration. J. Biomater. Sci. Polym. Ed. (2005) 16(12):1611-1621.
48. CLAASE MB, GRIJPMA DW, MENDES SC, DE BRUIJN JD, FEIJEN J: Porous PEOT/PBT scaffolds for bone tissue engineering: preparation, characterization, and in vitro bone marrow cell culturing. J. Biomed. Mater. Res. A. (2003) 64(2):291-300.
49. MA PX, CHOI JW: Biodegradable polymer scaffolds with well-defined interconnected spherical pore network. Tissue Eng. (2001) 7(1):23-33.
50. THOMSON RC, SHUNG AK, YASZEMSKI MJ: Polymer scaffold processing. In: Principles of Tissue Engineering. Lanza RP, Langer R, Vancanti J (Eds), Academic Press, USA (1997):251-262.
51. GOMES ME, RIBEIRO AS, MALAFAYA PB et al.: A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: morphology, mechanical and degradation behaviour. Biomaterials (2001) 22(9):883-889.
52. WHITAKER MJ, QUIRK RA, HOWDLE SM et al.: Growth factor release from tissue engineering scaffolds. J. Pharm. Pharmacol. (2001) 53(11):1427-1437.
53. CHUN KW, CHO KC, KIM SH et al.: Controlled release of plasmid DNA from biodegradable scaffolds fabricated using a thermally-induced phase-separation method. J. Biomater. Sci. Polym. Ed. (2004) 15(11):1341-1353.
54. JIN HJ, CHEN J, KARAGEORGIOU V et al.: Human bone marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials (2004) 25(6):1039-1047.
55. LIN CY, KIKUCHI N, HOLLISTER SJ: A novel method for biomaterial scaffold internal architecture design to match bone elastic properties with desired porosity. J. Biomech. (2004) 37(5):623-636.
56. LU HH, COOPER JA JR, MANUEL S et al.: Anterior cruciate ligament regeneration using braided biodegradable scaffolds: in vitro optimization studies. Biomaterials (2005) 26(23):4805-4816.
57. HENCH LL, POLAK JM: Third-generation biomedical materials. Science (2002) 295(5557):1014-1017.
58. BHATI RS, MUKHERJEE DP, MCCARTHY KJ et al.: The growth of chondrocytes into a fibronectin-coated biodegradable scaffold. J. Biomed. Mater. Res. (2001) 56(1):74-82.
59. NAITO M, FUNAKI C, HAYASHI T et al.: Substrate-bound fibrinogen, fibrin and other cell attachment-promoting proteins as a scaffold for cultured vascular smooth muscle cells. Atherosclerosis (1992) 96(2-3):227-234.
60. YANG Y, MAGNAY J, COOLING L, COOPER JJ, EL HAJ AJ: Effects of substrate characteristics on bone cell response to the mechanical environment. Med. Biol. Eng. Comput. (2004) 42(1):22-29.
61. SCOTCHFORD CA, CASCONE MG, DOWNES S et al.: Osteoblast responses to collagen-PVA bioartificial polymers in vitro: the effects of cross-linking method and collagen content. Biomaterials (1998) 19(1-3):1-11.
62. HEATH DJ, CHRISTIAN P, GRIFFIN M: Involvement of tissue transglutaminase in the stabilisation of biomaterial/tissue interfaces important in medical devices. Biomaterials (2002) 23(6):1519-1526.
63. OHYA Y, MATSUNAMI H, OUCHI T: Cell growth on the porous sponges prepared from poly(depsipeptide-co-lactide) having various functional groups. J. Biomater. Sci. Polym. Ed. (2004) 15(1):111-123.
64. YANG Y, PORTE MC, MARMEY P et al.: Covalent bonding of collagen on poly(L-lactic acid) by gamma irradiation. Nucl. Instr. Meth. B. (2003) 207(2):165-174.
65. SHIN H, JO S, MIKOS AG: Biomimetic materials for tissue engineering. Biomaterials (2003) 24(24):4353-4364. • This article describes how synthetic peptide sequences of ECM proteins as biomolecular recognition can be incorporated into biomaterials for tissue engineering.
66. DEE KC, ANDERSEN TT, BIZIOS R: Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials. J. Biomed. Mater. Res. (1998) 40(3):371-377.
67. YOO HS, LEE EA, YOON JJ et al.: Hyaluronic acid modified biodegradable scaffolds for cartilage tissue engineering. Biomaterials (2005) 26(14):1925-1933.
68. YOON JJ, SONG SH, LEE DS et al.: Immobilization of cell adhesive RGD peptide onto the surface of highly porous biodegradable polymer scaffolds fabricated by a gas foaming/salt leaching method. Biomaterials (2004) 25(25):5613-5620.
69. BUCK CA, HORWITZ AF: Cell surface receptors for extracellular matrix molecules. Annu. Rev. Cell Biol. (1986) 3:179-205.
70. GRZESIK WJ, ROBEY PR: Bone matrix RGD glycoproteins: immunolocalization and interaction with primary osteoblastic cells in vitro. J. Bone Miner. Res. (1994) 9:487-496.
71. HERN DL, HUBBELL JA: Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J. Biomed. Mater. Res. (1998) 39:266-276.
72. YANG XB, ROACH HI, CLARKE NM et al.: Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone (2001) 29(6):523-531.
73. MANJUBALA I, WOESZ A, PILZ C et al.: Biomimetic mineral-organic composite scaffolds with controlled internal architecture. J. Mater. Sci. Mater. Med. (2005) 16(12):1111-1119. •• This article details a good sample of constructing biomimetic scaffolds with osteoconductive components and defined internal architecture for bone and cartilage tissue engineering.
74. STEVENS MM, MAYER M, ANDERSON DG, WEIBEL DB, WHITESIDES GM, LANGER R: Direct patterning of mammalian cells onto porous tissue engineering substrates using agarose stamps. Biomaterials (2005) 26(36):7636-7641.
75. FUKUDA J, KHADEMHOSSEINI A, YEH J et al.: Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components. Biomaterials (2006) 27(8):1479-1486.
76. YANG Y, MAGNAY J, COOLING L et al.: Development of a 'mechano-active' scaffold for tissue engineering. Biomaterials (2002) 23:2119-2126.
77. WOOD MA, HUGHES S, YANG Y, EL HAJ AJ: Characterizing the efficacy of calcium channel agonist-release strategies for bone tissue engineering applications. J. Control. Release (2006) (In Press).
78. PEAKE MA, COOLING LM, MAGNAY JL, THOMAS PB, EL HAJ AJ: Selected contribution: regulatory pathways involved in mechanical induction of c-fos gene expression in bone cells. J. Appl. Physiol. (2000) 89(6):2498-2507.
79. HUBBELL JA: Materials as morphogenetic guides in tissue engineering. Curr. Opin. Biotechnol. (2003) 14(5):551-558.
80. LU Q, GANESAN K, SIMIONESCU DT et al.: Novel porous aortic elastin and collagen scaffolds for tissue engineering. Biomaterials (2004) 25(22):5227-5237.
81. CAMPODONICO F, BENELLI R, MICHELAZZI A et al.: Bladder cell culture on small intestinal submucosa as bioscaffold: experimental study on engineered urothelial grafts. Eur. Urol. (2004) 46(4):531-537.
82. DI MARTINO A, SITTINGER M, RISBUD MV: Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials (2005) 26(30):5983-5990.
83. CHUPA JM, FOSTER AM, SUMNER SR, MADIHALLY SV, MATTHEW HW: Vascular cell responses to polysaccharide materials: in vitro and in vivo evaluations. Biomaterials (2000) 21(22):2315-2322.
84. BAGNANINCHI P, YANG Y, MAFFULLI N et al.: Investigation of tennocytes proliferation under perfusion in microchannel chitosan scaffolds by optical coherence tomography. Proceedings of the Annual Meeting of the Tissue and Cell Engineering Society. London, UK (20-22 June 2005).
85. DOILLON CJ, WATSKY MA, HAKIM M et al.: A collagen-based scaffold for a tissue engineered human cornea: physical and physiological properties. Int. J. Artif Organs (2003) 26(8):764-773.
86. FREYRIA AM, YANG Y, CHAJRA H et al.: Optimisation of dynamic culture conditions: effects on biosynthetic activities of chondrocytes grown in collagen sponges. Tissue Eng. (2005) 11(5-6):674-684.
87. KOOB TJ, WILLIS TA, QIU YS et al.: Biocompatibility of NDGA-polymerized collagen fibers. II. Attachment, proliferation, and migration of tendon fibroblasts in vitro. J. Biomed. Mater. Res. (2001) 56(1):40-48.
88. GRIGOLO B, ROSETI L, FIORINI M et al.: Transplantation of chondrocytes seeded on a hyaluronan derivative (hyaff-11) into cartilage defects in rabbits. Biomaterials (2001) 22(17):2417-2424.
89. TURNER NJ, KIELTY CM, WALKER MG et al.: A novel hyaluronan-based biomaterial (Hyaff-11) as a scaffold for endothelial cells in tissue engineered vascular grafts. Biomaterials (2004) 25(28):5955-5964.
90. PEREIRA CS, CUNHA AM, REIS RL et al.: New starch-based thermoplastic hydrogels for use as bone cements or drug-delivery carriers. J. Mater. Sci. Mater. Med. (1998) 9(12):825-833.
91. AZEVEDO HS, GAMA FM, REIS RL: In vitro assessment of the enzymatic degradation of several starch based biomaterials. Biomacromolecules (2003) 4(6):1703-1712.
92. GOMES ME, REIS RL, CUNHA AM et al.: Cytocompatibility and response of osteoblastic-like cells to starch-based polymers: effect of several additives and processing. Biomaterials (2001) 22(13):1911-1917.
93. DOYLE C, TANNER ET, BONFIELD W: In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite. Biomaterials (1991) 12(9):841-847.
94. CHEN GQ, WU Q: The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials (2005) 26(33):6565-6578.
95. BACKDAHL H, HELENIUS G, BODIN A et al.: Mechanical properties of bacterial cellulose and interactions with smooth muscle cells. Biomaterials (2006) 27(9):2141-2149.
96. ALMANY L, SELIKTAR D: Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials (2005) 26(15):2467-2477.
97. HALSTENBERG S, PANITCH A, RIZZI S et al.: Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules (2002) 3(4):710-23.
98. TAKAHASHI Y, YAMAMOTO M, TABATA Y: Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and beta-tricalcium phosphate. Biomaterials (2005) 26(17):3587-3596.
99. TEMENOFF JS, MIKOS AG: Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials (2000) 21(23):2405-2412.
100. BENSAID W, TRIFFITT JT, BLANCHAT C et al.: A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials (2003) 24(14):2497-2502.
101. BALAKRISHNAN B, JAYAKRISHNAN A: Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds. Biomaterials (2005) 26(18):3941-3951.
102. SHIN H, QUINTEN RUHE P, MIKOS AG et al.: In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials (2003) 24(19):3201-3211.
103. CHANG TM: Semipermeable microcapsules. Science (1964) 146:524-525.
104. LI RH: Materials for immunoisolated cell transplantation. Adv. Drug Deliv. Rev. (1998) 33(1-2):87-109.
105. RIHOVA B: Immunocompatibility and biocompatibility of cell delivery systems. Adv. Drug Deliv. Rev. (2000) 42:65-80.
106. ULUDAG H, DE VOS P, TRESCO PA: Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. (2000) 42:29-64.
107. KLOCK G, PFEFFERMANN A, RYSER C et al.: Biocompatibility of mannuronic acid-rich alginates. Biomaterials (1997) 18(10):707-713.
108. HAQUE T, CHEN H, OUYANG W et al.: In vitro study of alginate-chitosan microcapsules: an alternative to liver cell transplants for the treatment of liver failure. Biotechnol. Lett. (2005) 27(5):317-322.
109. LOU WH, QIN XY, WU ZG: Preliminary research on biocompatibility of alginate chitosan-polyethyleneglycol microcapsules. Minerva Biotecnol. (2000) 12:235-240.
110. CELLESI F, TIRELLI N, HUBBELL JA: Towards a fully-synthetic substitute of alginate: development of a new process using thermal gelation and chemical cross-linking. Biomaterials (2004) 25(21):5115-5124.
111. YANG Y, ZHANG S, JONES G, MORGAN N, EL HAJ AJ: Phosphorylcholine- containing polymers for use in cell encapsulation. Artif. Cells Blood Substit. Immobil. Biotechnol. (2004) 32(1):91-104.
112. PUTNAM AJ, MOONEY DJ: Tissue engineering using synthetic extracellular matrices. Nat. Med. (1996) 2(7):824-826.
113. RICHARDSON TP, MURPHY WL, MOONEY DJ: Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. Crit. Rev. Eukaryot. Gene Expr. (2001) 11(1-3):47-58.
114. SIMMONS CA, ALSBERG E, HSIONG S et al.: Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone (2004) 35(2):562-569.
115. ROYCE SM, ASKARI M, MARRA KG: Incorporation of polymer microspheres within fibrin scaffolds for the controlled delivery of FGF-1. J. Biomater. Sci. Polym. Ed. (2004) 15(10):1327-1336.
116. LUTOLF MP, HUBBELL JA: Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. (2005) 23(1):47-55.
117. RICHARDSON TP, PETERS MC, ENNETT AB, MOONEY DJ: Polymeric system for dual growth factor delivery. Nat. Biotechnol. (2001) 19(11):1029-1034.
118. NIKKOLA L, SEPPALA J, ANDREU A et al.: Electrospun diclofenac sodium releasing nanoscaffold. J. Nanosci. Nanotechnol. (2006) (In Press).
119. SOHIER J, VLUGT TJ, CABROL N, VAN BLITTERSWIJK C, DE GROOT K, BEZEMER JM: Dual release of proteins from porous polymeric scaffolds. J. Control. Release (2006) 111(1-2):95-106. • This study developed a new approach for dual release of proteins from porous scaffolds, which can be extended to multiple-drug release systems in tissue engineering.